May 26, 2022
Article
Sacubitril/valsartan (Entresto)reduces the risk of hospitalization and death related to cardiovascular complications in patients with heart failure.
April 21, 2022
Evusheld has been found to significantly reduce the risk of developing symptomatic COVID-19.